Kite Pharma to Report Second Quarter 2016 Financial Results on August 8, 2016

Conference Call and Webcast Scheduled for 4:30 PM Eastern Time

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq:KITE) today announced that it will report second quarter 2016 financial results on Monday, August 8, 2016, after market close. The announcement will be followed by a live audio webcast and conference call at 4:30 PM Eastern Time (1:30 PM Pacific Time).

Audio Webcast

The webcast will be made available on the Company's website at www.kitepharma.com under the Investors tab in the Events and Presentations section. Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days.

Dial-In Information

Live (U.S. / Canada): (877) 301-8565
Live (International): (678) 562-4240
Confirmation number: 40985316

About Kite Pharma

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160801006187/en/

Kite Pharma
Greg Mann
VP, Investor Relations
gmann@kitepharma.com
or
For Media:
inVentiv Health
David Polk, 310-309-1029
david.polk@inventivhealth.com

Source: Kite Pharma, Inc.

News Provided by Acquire Media